TY - JOUR
T1 - The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia
AU - Komoda, Fusako
AU - Sekine, Takashi
AU - Inatomi, Jun
AU - Enomoto, Atsushi
AU - Endou, Hitoshi
AU - Ota, Toshiyuki
AU - Matsuyama, Takeshi
AU - Ogata, Tsutomu
AU - Ikeda, Masahiro
AU - Awazu, Midori
AU - Muroya, Koji
AU - Kamimaki, Isamu
AU - Igarashi, Takashi
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2004/7
Y1 - 2004/7
N2 - Recently, a urate transporter, hURAT1 (human uric acid transporter 1) encoded by SLC22A12, was isolated from the human kidney. hURAT1 is presumed to play the central role in reabsorption of urate from glomerular filtrate. In the present study, we analyzed SLC22A12 in seven unrelated Japanese patients with renal hypouricemia whose serum level of urate was less than 1.0 mg/dl, and their family members. We performed direct DNA sequencing of the exon and exon-intron boundaries of SLC22A12 using genomic DNA. Six of the seven patients (86%) possess mutations in SLC22A12. In five patients, a homozygous G to A transition at nucleotide 774 within exon 4 of SLC22A12, which forms a stop codon (TGA) at codon 258 (TGG), was identified (W258X). In one patient, the C to T transition within exon 3, which changes threonine at codon 217 to methionine (T217 M), and the W258X mutation were found (compound heterozygote). Thus, among 12 mutational alleles in six patients, 11 were the W258X mutation (92%). Family members with the heterozygous W258X mutation (carriers) show relatively low levels of serum urate. The present study demonstrates that homozygous W258X mutation is the predominant genetic cause of idiopathic renal hypouricemia in Japanese patients.
AB - Recently, a urate transporter, hURAT1 (human uric acid transporter 1) encoded by SLC22A12, was isolated from the human kidney. hURAT1 is presumed to play the central role in reabsorption of urate from glomerular filtrate. In the present study, we analyzed SLC22A12 in seven unrelated Japanese patients with renal hypouricemia whose serum level of urate was less than 1.0 mg/dl, and their family members. We performed direct DNA sequencing of the exon and exon-intron boundaries of SLC22A12 using genomic DNA. Six of the seven patients (86%) possess mutations in SLC22A12. In five patients, a homozygous G to A transition at nucleotide 774 within exon 4 of SLC22A12, which forms a stop codon (TGA) at codon 258 (TGG), was identified (W258X). In one patient, the C to T transition within exon 3, which changes threonine at codon 217 to methionine (T217 M), and the W258X mutation were found (compound heterozygote). Thus, among 12 mutational alleles in six patients, 11 were the W258X mutation (92%). Family members with the heterozygous W258X mutation (carriers) show relatively low levels of serum urate. The present study demonstrates that homozygous W258X mutation is the predominant genetic cause of idiopathic renal hypouricemia in Japanese patients.
KW - Renal hypouricemia
KW - Urate transporter
KW - W258X mutation
KW - hURAT1
UR - http://www.scopus.com/inward/record.url?scp=3142674476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3142674476&partnerID=8YFLogxK
U2 - 10.1007/s00467-004-1424-1
DO - 10.1007/s00467-004-1424-1
M3 - Article
C2 - 15054642
AN - SCOPUS:3142674476
SN - 0931-041X
VL - 19
SP - 728
EP - 733
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 7
ER -